(Q37738776)

22 August 2017

1 reference

title

Response assessment challenges in clinical trials of gliomas (English)

1 reference

22 August 2017

1

Patrick Y Wen

1 reference

22 August 2017

Andrew D Norden

2

1 reference

22 August 2017

Jan Drappatz

series ordinal

3

1 reference

22 August 2017

Eudocia Quant

series ordinal

4

1 reference

22 August 2017

publication date

1 January 2010

1 reference

22 August 2017

published in

Current Oncology Reports

1 reference

22 August 2017

volume

12

1 reference

22 August 2017

issue

1

1 reference

22 August 2017

page(s)

68-75

1 reference

Malignant gliomas: MR imaging spectrum of radiation therapy- and chemotherapy-induced necrosis of the brain after treatment.

22 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS11912-009-0078-3

Steroid-induced CT changes in patients with recurrent malignant glioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-009-0078-3

Postoperative changes in the brain: MR imaging findings in patients without neoplasms

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-009-0078-3

Immediate post-radiotherapy changes in malignant glioma can mimic tumor progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-009-0078-3

Cerebral radiation necrosis: incidence, outcomes, and risk factors with emphasis on radiation parameters and chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-009-0078-3

A randomized trial on dose-response in radiation therapy of low-grade cerebral glioma: European Organization for Research and Treatment of Cancer (EORTC) Study 22844.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-009-0078-3

Postoperative contrast enhancement in patients with brain tumor

21 January 2018

1 reference

12 December 2020

Post-surgical contrast enhancement mimicking residual brain tumour

1 reference

12 December 2020

New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada

1 reference

12 December 2020

Advanced MRI of adult brain tumors

1 reference

12 December 2020

18F-FDG PET of gliomas at delayed intervals: improved distinction between tumor and normal gray matter.

1 reference

12 December 2020

Phase II trial of single-agent bevacizumab followed by bevacizumab plus irinotecan at tumor progression in recurrent glioblastoma

1 reference

12 December 2020

End point assessment in gliomas: novel treatments limit usefulness of classical Macdonald's Criteria

1 reference

12 December 2020

Serial diffusion-weighted magnetic resonance imaging in cases of glioma: distinguishing tumor recurrence from postresection injury.

1 reference

12 December 2020

Relative cerebral blood volume values to differentiate high-grade glioma recurrence from posttreatment radiation effect: direct correlation between image-guided tissue histopathology and localized dynamic susceptibility-weighted contrast-enhanced pe

1 reference

12 December 2020

Corticosteroid-induced magnetic resonance imaging changes in patients with recurrent malignant glioma.

1 reference

12 December 2020

Neuroradiographic changes following convection-enhanced delivery of the recombinant cytotoxin interleukin 13-PE38QQR for recurrent malignant glioma

1 reference

12 December 2020

MR imaging and single-photon emission CT findings after gene therapy for human glioblastoma.

1 reference

12 December 2020

Bevacizumab plus irinotecan in recurrent glioblastoma multiforme

1 reference

12 December 2020

Response criteria for phase II studies of supratentorial malignant glioma

1 reference

12 December 2020

Antiangiogenic therapies for high-grade glioma

1 reference

12 December 2020

The clinical value of proton magnetic resonance spectroscopy in adult brain tumours.

1 reference

12 December 2020

Malignant gliomas in adults

1 reference

12 December 2020

Validation of neuroradiologic response assessment in gliomas: measurement by RECIST, two-dimensional, computer-assisted tumor area, and computer-assisted tumor volume methods

1 reference

12 December 2020

Distinction between glioma progression and post-radiation change by combined physiologic MR imaging

1 reference

12 December 2020

Diagnostic accuracy of 11C-methionine PET for differentiation of recurrent brain tumors from radiation necrosis after radiotherapy

1 reference

12 December 2020

Early necrosis following concurrent Temodar and radiotherapy in patients with glioblastoma

1 reference

12 December 2020

Comparison of one-, two-, and three-dimensional measurements of childhood brain tumors

1 reference

12 December 2020

Clinical and radiographic features of peritumoral infarction following resection of glioblastoma

1 reference

12 December 2020

Antiangiogenic therapy elicits malignant progression of tumors to increased local invasion and distant metastasis

1 reference

12 December 2020

MGMT promoter methylation status can predict the incidence and outcome of pseudoprogression after concomitant radiochemotherapy in newly diagnosed glioblastoma patients

1 reference

12 December 2020

Direct intracerebral delivery of cintredekin besudotox (IL13-PE38QQR) in recurrent malignant glioma: a report by the Cintredekin Besudotox Intraparenchymal Study Group

1 reference

12 December 2020

Magnetic resonance spectroscopy of the brain: review of metabolites and clinical applications

1 reference

12 December 2020

Imaging changes after stereotactic radiosurgery of primary and secondary malignant brain tumors

1 reference

12 December 2020

Effect of adding temozolomide to radiation therapy on the incidence of pseudo-progression

1 reference

12 December 2020

Efficacy, safety and patterns of response and recurrence in patients with recurrent high-grade gliomas treated with bevacizumab plus irinotecan.

1 reference

12 December 2020

Bevacizumab alone and in combination with irinotecan in recurrent glioblastoma

1 reference

12 December 2020

Anatomic, physiologic and metabolic imaging in neuro-oncology

1 reference

12 December 2020

Differentiating recurrent tumor from radiation necrosis: time for re-evaluation of positron emission tomography?

1 reference

12 December 2020

AZD2171, a pan-VEGF receptor tyrosine kinase inhibitor, normalizes tumor vasculature and alleviates edema in glioblastoma patients.

1 reference

12 December 2020

Mediators of glioblastoma resistance and invasion during antivascular endothelial growth factor therapy

1 reference

12 December 2020

Neuroimaging in patients with gliomas

1 reference

12 December 2020

New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1)

1 reference

12 December 2020

Comparison of stereotactic radiosurgery and brachytherapy in the treatment of recurrent glioblastoma multiforme

1 reference

12 December 2020

Outcomes and prognostic factors in recurrent glioma patients enrolled onto phase II clinical trials

1 reference

12 December 2020

Progression-free survival: an important end point in evaluating therapy for recurrent high-grade gliomas

1 reference

12 December 2020

Positron emission tomography with O-(2-[18F]fluoroethyl)-l-tyrosine versus magnetic resonance imaging in the diagnosis of recurrent gliomas

1 reference

12 December 2020

Long-term efficacy of early versus delayed radiotherapy for low-grade astrocytoma and oligodendroglioma in adults: the EORTC 22845 randomised trial

1 reference

12 December 2020

Associations among magnetic resonance spectroscopy, apparent diffusion coefficients, and image-guided histopathology with special attention to radiation necrosis

1 reference

12 December 2020

Neurologic complications of radiation therapy

1 reference

12 December 2020

Early postoperative magnetic resonance imaging following nonneoplastic cortical resection

1 reference

12 December 2020

Incidence of early pseudo-progression in a cohort of malignant glioma patients treated with chemoirradiation with temozolomide

1 reference

12 December 2020

Anti-VEGF antibody treatment of glioblastoma prolongs survival but results in increased vascular cooption

1 reference

12 December 2020

Disease progression or pseudoprogression after concomitant radiochemotherapy treatment: pitfalls in neurooncology

1 reference

12 December 2020

Differentiation of recurrent glioblastoma multiforme from radiation necrosis after external beam radiation therapy with dynamic susceptibility-weighted contrast-enhanced perfusion MR imaging

1 reference

12 December 2020

Convection-enhanced delivery of cintredekin besudotox (interleukin-13-PE38QQR) followed by radiation therapy with and without temozolomide in newly diagnosed malignant gliomas: phase 1 study of final safety results

1 reference

12 December 2020

Comparison of linear and volumetric criteria in assessing tumor response in adult high-grade gliomas

1 reference

12 December 2020

Clinical features, mechanisms, and management of pseudoprogression in malignant gliomas

1 reference

12 December 2020

Transient postictal MRI changes in patients with brain tumors may mimic disease progression

1 reference

12 December 2020

Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma

1 reference

12 December 2020

An exploratory survival analysis of anti-angiogenic therapy for recurrent malignant glioma

1 reference

12 December 2020

Clinical applications of PET in brain tumors

1 reference

12 December 2020

Infiltrative patterns of glioblastoma spread detected via diffusion MRI after treatment with cediranib

1 reference

12 December 2020

CT and MR imaging after placement of the GliaSite radiation therapy system to treat brain tumor: initial experience.

1 reference

12 December 2020

10.1007/S11912-009-0078-3

Identifiers

DOI

1 reference

release_tuim46ykmvejbnjfwqeylwesne

22 August 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/tuim46ykmvejbnjfwqeylwesne

24 November 2022

mapped directly with Wikidata item

1 reference